17 September 2009

Who’s doing FBDD?

Lots of companies are using FBDD, but aside from big pharma it’s not always easy to find them. As a public service we have started a running list with live links. This first installment is taken largely from a nice review by Wendy Warr in the JCAMD special issue we highlighted; we’ve removed companies that have been bought or ceased working in FBDD.

Astex Therapeutics
Beactica
BioLeap
BioSolveIT
Carmot Therapeutics
Crystax Pharmaceuticals
deCODE Chemistry and Biostructures
Evotec
Graffinity Pharmaceuticals
IOTA Pharmaceuticals
Locus Pharmaceuticals
MEDIT
Plexxikon
Proteros Fragments
Pyxis Discovery
Structure Based Design
Vernalis
Zenobia Therapeutics
ZoBio

I’m sure there are plenty of omissions; put them in the comments and we’ll add them in the next update.

6 comments:

Pascal said...

Hi,
First, thanks for this blog.
Second, NovAliX is doing FBDD too:
http://www.novalix.com
Regards,
Pascal

Fabio said...

Hi - Thanks for the message.

Nerviano Medical Sciences is in the game too

www.nervainoms.com

Fabio said...

... sorry, the correct website is:

www.nervianoms.com

thanks

Jessica said...

A new company has entered the field of fragments, Sprint Bioscience. Website: www.sprintbioscience.com

Johan said...

Hi,

iNovacia is doing FBDD.
http://wwww.inovacia.se

Best regards,

Johan

Dave said...

Genzyme is active in FBLD.